Condition
Minor Ischemic Stroke
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 2 (2)
P 3 (1)
Trial Status
Completed2
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07322835Not Yet RecruitingPrimary
Efficacy and Safety of Reperfusion Therapy for Minor Ischemic Stroke in China
NCT06414499Phase 3RecruitingPrimary
Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ
NCT02295826Phase 2Completed
Dabigatran Following Transient Ischemic Attack and Minor Stroke
NCT01769703Phase 2Completed
Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke
Showing all 4 trials